MolNFT v1 · #22819 · protein

Mechanism of molecular recognition. structural aspects of 3,3'-diiodo- L-thyronine binding to human serum transthyretin

1THA: “Mechanism of molecular recognition. structural aspects of 3,3'-diiodo- L-thyronine binding to human serum…”. X-ray diffraction, 1 ligand (T33), 1 pocket (best druggability 0.33). MolNFT v1 #22819 on GenesisL1: 3D structure, binding…

PDB: 1THA
Type: protein
Length: 234 residues
Chains: 2
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Transthyretin
UniProt: P02766
Ligands: T33
Pockets: 1 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 50% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Transthyretin	protein	118	7% helix, 50% strand	P02766
B	Transthyretin	protein	116	5% helix, 49% strand	P02766

Ligands and binding sites

T33 · 3,3'-deiodo-thyroxine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	69	0.33	0.76	15	empty

Interfaces

1 interface between chains.

A–B · 935 Å² buried · 19 hydrogen bonds · protein-protein

Compared structures

1THA · Mechanism of molecular recognition. structural aspects of 3,3'-diiodo-L-thyronine binding… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P02766
Elsewhere: RCSB PDB 1THA · PDBe 1THA · UniProt P02766

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.